Population pharmacokinetics of busulfan in patients with myelofibrosis
29 May 2022, by Kroemer
Adrin Dadkah, our joint PhD student with the University Medical Centre (UKE) hospital pharmacy, developed a population pharmacokinetic model for busulfan and its metabolite sulfolane in patients with myelofibrosis undergoing hematopoietic stem cell transplantation.